CARLA: THE BREAKING NEWS IS COMING OUT OF BIRMINGHAM WHERE THE UAV HEALTH SYSTEM IS LOSING ITS LEADER. THE CEO WAS NAMED AS THE PRESIDENT AND CEO OF -- HE IS SLATED TO START THAT NEW JOB IN SEPTEMBER AND WE ARE WORKING TO GET MO
UAB Health System CEO leaving for Memorial Sloan Kettering Cancer Center in New York
Updated: 12:08 PM CDT Jun 27, 2022
UAB Health System CEO Dr. Selwyn Vickers has been named the new president and CEO of Memorial Sloan Kettering Cancer Center in New York. Vickers, 62, of Demopolis, Ala., is a world-renowned surgeon, pancreatic cancer researcher, a pioneer in health disparities research and a member of the prestigious Institute of Medicine of the National Academy of Sciences. Vickers became dean of the Heersink School of Medicine in 2013 and was named CEO of UAB Health System and UAB/Ascension St. Vincent’s Alliance in January 2022. He was a member of the UAB surgical faculty from 1994 to 2006. “For 135 years, MSK has set the standard for excellence in caring for patients and finding new treatments and cures for cancer, and it is arguably the world’s preeminent center for the training of the next generation of scientific and physician leaders,” said Vickers. “The basic science programs of the Sloan Kettering Institute have led the world in cancer discovery science and translational research, and I am confident that MSK is on the path to tackle one of the world’s greatest threats to life, cancer. I am honored to have the opportunity to work with the pioneering researchers and dedicated doctors, nurses, and staff to build on MSK’s extraordinary legacy.”Under Vickers' leadership, the Heersink School of Medicine experienced significant growth, supported by a $95 million gift that led to its naming, and benefitted from transformative National Institutes of Health research growth, adding $100 million in new NIH funding.“Dr. Vickers is an extraordinary surgeon-scientist with a proven track record of success in leading complex academic medical centers, building innovative academic and research programs, and strengthening clinical care,” said Scott Stuart, Chair of the Memorial Sloan Kettering Cancer Center Boards of Trustees and Governing Trustees. "Throughout his career, he has demonstrated a passion for unlocking treatments and cures for cancer. Dr. Vickers is a charismatic and compassionate leader who is uniquely qualified to shepherd this great organization into the future.”Vickers, a board-certified surgeon and former president of the American Surgical Association, completed his professional and surgical training at the Johns Hopkins University School of Medicine and Hospital, including a chief residency and surgical oncology fellowship.
NEW YORK — UAB Health System CEO Dr. Selwyn Vickers has been named the new president and CEO of Memorial Sloan Kettering Cancer Center in New York.
Vickers, 62, of Demopolis, Ala., is a world-renowned surgeon, pancreatic cancer researcher, a pioneer in health disparities research and a member of the prestigious Institute of Medicine of the National Academy of Sciences. Vickers became dean of the Heersink School of Medicine in 2013 and was named CEO of UAB Health System and UAB/Ascension St. Vincent’s Alliance in January 2022. He was a member of the UAB surgical faculty from 1994 to 2006.
“For 135 years, MSK has set the standard for excellence in caring for patients and finding new treatments and cures for cancer, and it is arguably the world’s preeminent center for the training of the next generation of scientific and physician leaders,” said Vickers. “The basic science programs of the Sloan Kettering Institute have led the world in cancer discovery science and translational research, and I am confident that MSK is on the path to tackle one of the world’s greatest threats to life, cancer. I am honored to have the opportunity to work with the pioneering researchers and dedicated doctors, nurses, and staff to build on MSK’s extraordinary legacy.”
Under Vickers' leadership, the Heersink School of Medicine experienced significant growth, supported by a $95 million gift that led to its naming, and benefitted from transformative National Institutes of Health research growth, adding $100 million in new NIH funding.
“Dr. Vickers is an extraordinary surgeon-scientist with a proven track record of success in leading complex academic medical centers, building innovative academic and research programs, and strengthening clinical care,” said Scott Stuart, Chair of the Memorial Sloan Kettering Cancer Center Boards of Trustees and Governing Trustees. "Throughout his career, he has demonstrated a passion for unlocking treatments and cures for cancer. Dr. Vickers is a charismatic and compassionate leader who is uniquely qualified to shepherd this great organization into the future.”
Vickers, a board-certified surgeon and former president of the American Surgical Association, completed his professional and surgical training at the Johns Hopkins University School of Medicine and Hospital, including a chief residency and surgical oncology fellowship.